Literature DB >> 6600719

Establishment and characterization of a human non-secretory plasmacytoid cell line and its hybridization with human B cells.

R E Ritts, A Ruiz-Argüelles, K G Weyl, A L Bradley, B Weihmeir, D J Jacobsen, B L Strehlo.   

Abstract

A human non-secretory plasmacytoid cell line has been established for 6 years in more than 170 passages. Over 300 passages have been made from several early and late passages. The cell line is karyotypically normal, easily grown and has the characteristic features of a non-secretory plasmablast. Its characteristics suggest its use for hybridization by new methods as well as a study of its secretory defect. HPRT-negative phenotypic mutants can be derived from this line and a single polyploid clone has also been isolated. Hybridization with the HPRT+ and HPRT- lines X human B cells is described.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600719     DOI: 10.1002/ijc.2910310202

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Development of human monoclonal antibodies: A review.

Authors:  T Lindl
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Spontaneous expression of a low affinity Fc receptor for IgA (Fc alpha R) on human B cell lines.

Authors:  I Millet; F Briere; C Vincent; F Rousset; C Andreoni; J E De Vries; J P Revillard
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

3.  Generating human monoclonal antibodies.

Authors:  A M Neville; P A Edwards; M J O'Hare
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.

Authors:  N N Teng; K S Lam; F Calvo Riera; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

Review 5.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

6.  HAB-1, a new heteromyeloma for continuous production of human monoclonal antibodies.

Authors:  G Faller; H P Vollmers; I Weiglein; A Marx; C Zink; M Pfaff; H K Müller-Hermelink
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.